1. Home
  2. PHAR vs SIBN Comparison

PHAR vs SIBN Comparison

Compare PHAR & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$9.95

Market Cap

793.4M

Sector

Health Care

ML Signal

N/A

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

N/A

Current Price

$18.41

Market Cap

778.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PHAR
SIBN
Founded
1988
2008
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
793.4M
778.8M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
PHAR
SIBN
Price
$9.95
$18.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
★ $34.35
$25.00
AVG Volume (30 Days)
32.7K
★ 481.6K
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.33
EPS
★ N/A
N/A
Revenue
N/A
★ $67,301,000.00
Revenue This Year
$1.92
$15.53
Revenue Next Year
$8.85
$15.64
P/E Ratio
$3,041.22
★ N/A
Revenue Growth
N/A
★ 21.53
52 Week Low
$9.62
$11.48
52 Week High
$21.34
$21.89

Technical Indicators

Market Signals
Indicator
PHAR
SIBN
Relative Strength Index (RSI) 38.55 54.10
Support Level $9.62 $16.34
Resistance Level $11.60 $19.35
Average True Range (ATR) 0.40 0.54
MACD -0.05 0.04
Stochastic Oscillator 7.95 60.39

Price Performance

Historical Comparison
PHAR
SIBN

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: